Repare Therapeutics Inc. (RPTX) Financials
RPTX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | 263.1 million | 31.1 million |
| 2023-12-31 | 253.9 million | 41.8 million |
| 2023-09-30 | 286.4 million | 53.0 million |
| 2023-06-30 | 301.6 million | 56.2 million |
RPTX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-03-31 | 11.9 million | 6.5 million |
| 2023-12-31 | -28.6 million | 6.4 million |
| 2023-09-30 | -32.9 million | 6.4 million |
| 2023-06-30 | -35.4 million | 6.3 million |
RPTX Net Income
No data available :(
RPTX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | 237.0 million | - | 2.8 million |
| 2023-12-31 | 223.6 million | - | 3.4 million |
| 2023-09-30 | 250.1 million | - | 3.9 million |
| 2023-06-30 | 280.7 million | - | 4.5 million |
RPTX Shares Outstanding
RPTX Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | - | 32.5 million | 8.6 million | - |
| 2023-12-31 | 398000 | 34.5 million | 8.6 million | -116000 |
| 2023-09-30 | - | 32.7 million | 7.9 million | - |
| 2023-06-30 | 1.1 million | 33.8 million | 8.7 million | - |
RPTX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | 52.4 million | 501000 |
| 2023-12-31 | 13.0 million | 506000 |
| 2023-09-30 | 2.2 million | 1.0 million |
| 2023-06-30 | 30.2 million | 1.1 million |
RPTX
Price: $3.55
52 week price:
Earnings Per Share: -2.23 USD
P/E Ratio: -3.64
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 108000
Market Capitalization: 148.6 million